Revelation Biosciences Announces Board Changes
Ticker: REVBW · Form: 8-K · Filed: May 28, 2025 · CIK: 1810560
| Field | Detail |
|---|---|
| Company | Revelation Biosciences, Inc. (REVBW) |
| Form Type | 8-K |
| Filed Date | May 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors
TL;DR
Rev Bio board shake-up: new directors in, some officers out.
AI Summary
Revelation Biosciences, Inc. announced on May 23, 2025, a change in its board of directors. Specifically, the company reported the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for its officers.
Why It Matters
Changes in a company's board of directors can signal shifts in strategy, governance, or operational focus, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board changes can introduce uncertainty about future strategy and leadership stability.
Key Players & Entities
- REVELATION BIOSCIENCES, INC. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- May 23, 2025 (date) — Date of earliest event reported
FAQ
What specific roles have been affected by the departure of officers?
The filing indicates the departure of 'certain officers' but does not specify their exact roles in this section.
Who are the newly elected directors?
The filing states that directors have been elected but does not name them in this excerpt.
What are the details of the updated compensatory arrangements?
The filing mentions updates to compensatory arrangements for certain officers but does not provide specific details in this excerpt.
What is the exact date of the reported board changes?
The earliest event reported, related to these changes, is dated May 23, 2025.
Is this filing related to a specific event or ongoing situation?
This is a current report (8-K) filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating it reports a material event.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding REVELATION BIOSCIENCES, INC. (REVBW).